Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Colchicine and Low-dose Naltrexone on COVID-19 (COLTREXONE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04756128
Recruitment Status : Enrolling by invitation
First Posted : February 16, 2021
Last Update Posted : February 18, 2021
Sponsor:
Collaborator:
Park Nicollet Foundation
Information provided by (Responsible Party):
Daniel P. Delaney, PharmD, BCIDP, HealthPartners Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : December 31, 2021
Estimated Study Completion Date : December 31, 2021